Bibliographic Info
GuidelineConsolidated guidelines on differentiated HIV testing services.
Year of Publication2024
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
Western blotting and line immunoassays should not be used in national HIV testing strategies and algorithms
Notes and Remarks
Countries should move away from these assays (tests) and instead select products, such as rapid diagnostic tests (RDTs) and enzyme immunoassays (EIAs), which will facilitate access to and scale-up of HIV testing, treatment and prevention services.
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Consolidated guidelines on HIV testing services, 2019
Year2020
InstitutionWHO
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO